Phacilitate Leaders Forum

Why attend?

Why attend?

Hear from the entire ecosystem

why attend phacilitate leaders europe

To develop a viable advanced therapy, collaboration is key. Phacilitate Leaders Europe connects you with critical voices from healthcare, academia, industry and investment to exchange ideas, create new solutions and unlock the gates to commercial viability.

Immerse yourself in experiences designed to challenge, inspire & support your learning

why attend phacilitate leaders europe

We’re making it easier for you to engage and learn by challenging the status quo in events. This year you’ll spot unique content formats, new presentation styles and a variety of exciting event tech that makes it easier than ever to meet your objectives onsite. 

Explore the latest in cell and gene therapy, immuno-oncology & investment for advanced therapies all under one roof

why attend phacilitate leaders europe

Open the door to more opportunities by networking between Cell and Gene Therapy Europe, Immuno-Oncology Frontiers and Investment for Advanced Therapies content tracks on the same ticket! You’ll have more meetings in two days than you will all summer and will gain access to a wider audience of potential clients and new partners. 

Connect with business leaders shaping the future of ATMPs

why attend phacilitate leaders europe

Phacilitate Leaders Europe attracts more C-level and VP level attendees than any other advanced therapies meeting in Europe, they recognize this as the place to nurture, challenge and explore perceptions around the future of advanced therapies. When you join this audience, you take a big step towards protecting and future proofing your own development strategies.  

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd

 

Show the sponsors